Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-28 @ 3:13 PM
Study NCT ID:
NCT00434668
Status:
COMPLETED
Last Update Posted:
2010-11-30
First Post:
2007-02-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer
Sponsor:
University Hospital, Antwerp
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TOGA 0501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Prof Dr P Germonpré
Old Organization:
Thoracale Oncologie Groep Antwerpen